LIPID ABNORMALITY IN HYPERTENSIVE SUDANESE PATIENTS IN SHENDI LOCALITY, SUDAN
DOI:
https://doi.org/10.29121/granthaalayah.v3.i6.2015.2994Keywords:
Hypertension, Lipid Profile, Dyslipidemia, Cardiovascular Risk Factors, Cardiovascular DiseaseAbstract [English]
Hypertension is commonly associated with other cardiovascular risk factors, such as obesity, diabetes, and dyslipidaemia. The presence of these cardiovascular risk factors and the resulting endothelial dysfunction may play a role in the pathophysiology of hypertension. Dyslipidaemia, a strong predictor of cardiovascular disease.
This cross-sectional study was conducted at Shendi locality from February 2011 to July 2012. The patients underwent a clinical assessment, which included history (a questionnaire) and clinical examination. 100 hypertensive patients. The age limits was 40 to 60 years.
There was sharp and definite increase in the percentage of patients having >200mg/dl total cholesterol after four years of diabetes mellitus from (28-34%) to (41%). There was a sharp increase in the percentage of patients having >150mg/dl of low density lipoproteins after 6 years of diabetes mellitus from(8-9%) to (14.2%). There was also an increase in the percentage of patients having <160mg/dl of triglycerides after four years of diabetes mellitus from 53% to 61% of diabetes.
Downloads
References
Maton A. Human Biology and Health Englewood Cliffs, New Jersey: Prentice Hall; 1993.
McGill HC, Jr., McMahan CA, Zieske AW, et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. ArteriosclerThrombVasc Biol. Aug 2000;20(8):1998-2004.
CDC, US. Chronic Disease Overview: Center for Disease control and Prevention 1999.
Department of Health, Executive Yuan, Taiwan. Health and Vital statistics-vital statistics2005.
Rainwater DL, McMahan CA, Malcom GT, et al. Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. The PDAY Research Group. ArteriosclerThrombVasc Biol. Mar 1999;19(3):753-761.
Ahmed AM et al. Pattern of hospital mortality among diabetic patients in Sudan. PractDiabInt March 2000; Vol. 17 No. 2. DOI: https://doi.org/10.1002/(SICI)1528-252X(200003/04)17:2<41::AID-PDI29>3.0.CO;2-S
Halperin RO. Dyslipidemia and the Risk of Incident Hypertension in Men.Hypertension 2006;47:45-50. DOI: https://doi.org/10.1161/01.HYP.0000196306.42418.0e
Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med 2003;139:761–776. DOI: https://doi.org/10.7326/0003-4819-139-9-200311040-00011
Castelli WP, Anderson K. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med 1986;80:23–32. DOI: https://doi.org/10.1016/0002-9343(86)90157-9
Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 1987;257:2176 –2180. DOI: https://doi.org/10.1001/jama.1987.03390160062027
Gaziano JM, Sesso HD, Breslow JL, Hennekens CH, Buring JE. Relation between systemic hypertension and blood lipids on the risk of myocardial infarction. Am J Cardiol 1999;84:768 –773. DOI: https://doi.org/10.1016/S0002-9149(99)00435-X
Haffner SM, Miettinen H, Gaskill SP, Stern MP. Metabolic precursors of hypertension: the San Antonio Heart Study. Arch Intern Med 1996;156: 1994–2000. DOI: https://doi.org/10.1001/archinte.1996.00440160106013
Nohria A, Garrett L, Johnson W, Kinlay S, Ganz P, Creager MA. Endothelin-1 and vascular tone in subjects with atherogenic risk factors. Hypertension 2003;42:43– 48. DOI: https://doi.org/10.1161/01.HYP.0000074426.71392.D8
Dyslipidemia Can Promote Hypertension in Men. Available on: http://www.diabetesincontrol.com/articles/53-diabetes-news/3355- (Accessed on 24 January 2013).
Downloads
Published
How to Cite
Issue
Section
License
With the licence CC-BY, authors retain the copyright, allowing anyone to download, reuse, re-print, modify, distribute, and/or copy their contribution. The work must be properly attributed to its author.
It is not necessary to ask for further permission from the author or journal board.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.